# Commission Regulation (EU) No 440/2011 of 6 May 2011 on the authorisation and refusal of authorisation of certain health claims made on foods and referring to children’s development and health (Text with EEA relevance), Annex II

Extent: E+W+S+N.I.

Rejected health claims
Application – Relevant provisions of Regulation (EC) No 1924/2006
Nutrient, substance, food or food category
Claim
EFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and health
Docosahexaenoic acid (DHA) and arachidonic acid (ARA)
Docosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children.
Q-2008-212
Article 14(1)(b) health claim referring to children’s development and health
Lipil®
Lipil® contributes to optimal brain development of infants and young children.
Q-2008-690
Article 14(1)(b) health claim referring to children’s development and health
Enfamil® Premium
Enfamil® Premium contributes to optimal brain development of infants and young children.
Q-2008-691

---
Source: https://www.legislation.gov.uk/eur/2011/440/annex/II (the official version)
Page: https://openlegislation.uk/eu-regulation-2011-440/annex-II
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.